NASDAQ:CRVS

Corvus Pharmaceuticals Earning Date

USA |NASDAQ |USD

CRVS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 27, 2021 Sep 2021 $-0.26 $-0.28 $-0.33
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 27, 2021 Sep 2021 $0.00 $0.00 $0.00

Corvus Pharmaceuticals's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 2021.

CRVS Earnings Date & History Chart

CRVS Earnings & Revenue Forecast

CRVS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.22 $-0.29 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-1.07 $-1.23 $-0.91
Dec 2022 3 $-0.90 $-0.95 $-0.79

CRVS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.22 $-0.22 $-0.39
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.07 $-1.07 $-1.42
Dec 2022 0 / 0 $-0.90 $-0.90 $-1.16

CRVS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $45.50M $0.00 $136.50M

CRVS Earnings Date & Revenue History

CRVS Earnings History

|
Show More
Show More

CRVS Revenue History

|
Show More
Show More

Corvus Pharmaceuticals Next Earnings Date & Report

CRVS Next Earnings Date & Report Preview: Sep 2021 (FQ)

CRVS's next earnings date is Wednesday, Oct 27, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Corvus Pharmaceuticals's next quarterly earnings is $-0.26, with a low EPS estimation of $-0.35, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.26, the last 2 month trend is $-0.26, and the 3 month trend is $-0.38.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Corvus Pharmaceuticals Previous Earnings Dates & Reports

CRVS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Corvus Pharmaceuticals's previous earnings date was Aug 2, 2021 for its fiscal quarter ended Jun 30, 2021.

CRVS's earnings per share (EPS) was $-0.28, beating the consensus analysts forecast of $-0.31 by 10.40%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -17.65%, and higher than the same period a year before (Jun 2020) by -22.22%.

Revenues were $0.00.

The company reported a net income of $-11.75M.

Free cash flow for the quarter was $-12.65M , compared to $-8.79M last quarter and $-9.49M a year before.

CRVS ended the quarter with $1.78M in total debt, a decrease of -12.98% compared to the previous quarter, and a decrease of -35.36% compared to the same quarter a year before.

CRVS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Corvus Pharmaceuticals's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

CRVS's earnings per share (EPS) was $-1.47, missing the consensus analysts forecast of $-1.46 by 0.73% , and higher than the previous year's EPS (Dec 2019) by -7.50%.

Revenues were $0.00.

The company reported a net income of $-6.00M.

Corvus Pharmaceuticals reported a free cash flow of $-34.85M for its fiscal year, compared to $-37.35M a year ago.

The company ended the fiscal year with $2.31M in total debt, a decrease of -27.54% compared to the previous year.